Safety and efficacy of immunotherapy plus chemotherapy as neoadjuvant treatment for patients with locally advanced gastric cancer: a retrospective cohort study

Conclusions: PD-1 inhibitors plus chemotherapy demonstrated promising efficacy, with encouraging pCR and survival outcomes in a neoadjuvant setting for patients with LAGC. The combined therapy also showed a good safety profile.

http://link.springer.com/10.1007/s10637-023-01379-y

Source: Investigational New Drugs - June 27, 2023 Category: Drugs & Pharmacology Source Type: research